Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3340372

CC1(C)CCC(NCc2ccc(-c3cccc(C(=O)NCCCc4ccccc4)c3)cc2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.44
OPRD1 P41143 1/20 0.44
OPRK1 P41145 1/20 0.44
MLYCD O95822 2/20 0.44
F10 P00742 1/20 0.44
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
CCR2 P41597 2/20 0.43
HTR5A P47898 4/20 0.43
KDM4B O94953 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
HDAC1 Q13547 2/20 0.42
EPHX2 P34913 1/20 0.42
NR1H4 Q96RI1 1/20 0.42
SLC2A1 P11166 1/20 0.42
HTR1A P08908 1/20 0.42
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
HTR1D P28221 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3340242 0.95 HTR5A (0.46) OPRM1OPRD1OPRK1MLYCDALDH1A1
SCHEMBL12651252 0.95 F10 (0.48) OPRM1OPRD1OPRK1F10ALDH1A1
Trifluoroacetic Acid SCHEMBL3340179 0.94 HTR5A (0.45) OPRM1OPRD1OPRK1HTR5ANPC1
Trifluoroacetic Acid SCHEMBL3341197 0.91 EPHX2 (0.52) OPRM1OPRD1OPRK1CCR2HTR5A
SCHEMBL12651379 0.90 RAB9A (0.49) OPRM1OPRD1OPRK1ALDH1A1HPGD
SCHEMBL12651148 0.89 EPHX2 (0.49) OPRM1OPRD1OPRK1ALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL3340186 0.86 HDAC1 (0.46) OPRM1OPRD1OPRK1HTR5ARAB9A
SCHEMBL12651503 0.86 EPHX2 (0.58) RAB9AHDAC1EPHX2NR1H4PRKD1
Trifluoroacetic Acid SCHEMBL3338278 0.83 OPRM1 (0.50) OPRM1OPRD1OPRK1CCR2HTR5A
SCHEMBL15633887 0.81 F10 (0.48) OPRM1OPRD1OPRK1F10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140323487-A1 Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors GLAXOSMITHKLINE LLC 2014-10-30 US disclosed
US-20100113512-A1 METHOD OF TREATMENT USING NOVEL ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS IGNAR DIANE MICHELE 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113512-A1 METHOD OF TREATMENT USING NOVEL ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS OPRL1, OPRD1, OPRK1 OPRM1 4/4885OPRD1 2/4885OPRK1 3/4885
US-20140323487-A1 Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors OPRL1, OPRM1, OPRK1 OPRM1 2/4885OPRD1 4/4885OPRK1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.